Cargando…
A Placebo-Controlled Study on the Effects of the Glucagon-Like Peptide-1 Mimetic, Exenatide, on Insulin Secretion, Body Composition and Adipokines in Obese, Client-Owned Cats
Glucagon-like Peptide-1 mimetics increase insulin secretion and reduces body weight in humans. In lean, healthy cats, short-term treatment has produced similar results, whereas the effect in obese cats or with extended duration of treatment is unknown. Here, prolonged (12 weeks) treatment with the G...
Autores principales: | Hoelmkjaer, Kirsten M., Wewer Albrechtsen, Nicolai J., Holst, Jens J., Cronin, Anna M., Nielsen, Dorte H., Mandrup-Poulsen, Thomas, Bjornvad, Charlotte R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852899/ https://www.ncbi.nlm.nih.gov/pubmed/27136422 http://dx.doi.org/10.1371/journal.pone.0154727 |
Ejemplares similares
-
Management of obesity in cats
por: Hoelmkjaer, Kirsten M, et al.
Publicado: (2014) -
Methods and Guidelines for Measurement of Glucagon in Plasma
por: Holst, Jens J., et al.
Publicado: (2019) -
Glucagon Receptor Signaling and Lipid Metabolism
por: Galsgaard, Katrine D., et al.
Publicado: (2019) -
Association of circulating adipokine concentrations with indices of adiposity and sex in healthy, adult client owned cats
por: Williams, Maggie C., et al.
Publicado: (2019) -
Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)